ALB and Cirrhosis: One randomized prospective study in patients with cirrhosis presenting with sepsis-induced hypotension and not yet on vasopressors found that 20% albumin administration (0.5–1 g/kg over 3 h) was superior to PlasmaLyte (30 mL/kg over 3 h) in achieving a target MAP > 65 at 3 h (62% vs. 22%, p < 0.001) [12].